04/12/2024
3:57 PM | Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
4:01 PM | Processa Pharmaceuticals (Issuer)
Young David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:50 PM | Guy Wendy (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:52 PM | Bigora Sian (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:55 PM | Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
7:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
11:05 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/21/2024
4:25 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
3:22 PM | Processa Pharmaceuticals (Issuer)
Young David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:30 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
5:32 PM | Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:34 PM | Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:37 PM | Ng George K (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
9:46 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2024
11:15 PM | Processa Pharmaceuticals (Filer)
| Form EFFECT | |
01/25/2024
7:35 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
7:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
7:30 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
3:30 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
7:55 AM | Processa Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/19/2023
8:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
4:18 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
2:10 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
10:30 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
1:45 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
4:31 PM | Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
| Form 4/A | |
10/16/2023
8:15 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
4:56 PM | Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
4:58 PM | Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
5:01 PM | Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
5:04 PM | Ng George K (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
5:07 PM | Guy Wendy (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
4:54 PM | Processa Pharmaceuticals (Issuer)
Young David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:00 PM | Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:03 PM | Processa Pharmaceuticals (Issuer)
Young David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:05 PM | Pannu Geraldine (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
3:51 PM | Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
9:00 AM | Processa Pharmaceuticals (Filer)
| Form DEF 14A | |
10/05/2023
9:01 AM | Processa Pharmaceuticals (Filer)
| Form DEFA14A | |
09/25/2023
3:09 PM | Processa Pharmaceuticals (Filer)
| Form PRE 14A | |
09/21/2023
4:29 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad) See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space. Click to read |
08/17/2023
11:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
9:30 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
5:35 PM | Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
5:38 PM | Neal James R (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
5:26 PM | Pannu Geraldine (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
5:29 PM | Baluch Khoso (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
5:33 PM | Processa Pharmaceuticals (Issuer)
THOMPSON VIRGIL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
3:18 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
11:30 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
1:05 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/18/2023
2:24 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
9:00 AM | Processa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
